HSIC vs PROF · P/E 24, rev $12.67B vs rev $10.7M
Henry Schein Inc (HSIC) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported HSIC revenue for 2024-12-28 was $12.67B. Net income was $398.0M. Revenue was up 2.7% from 2023-12-30 to 2024-12-28. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. PROF currently screens at market cap $238.7M.
Not investment advice. Open the HSIC and PROF stock pages for the full models.
Not investment advice.